SLNO vs. NVDA
Compare and contrast key facts about Soleno Therapeutics, Inc. (SLNO) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SLNO or NVDA.
Correlation
The correlation between SLNO and NVDA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SLNO vs. NVDA - Performance Comparison
Key characteristics
SLNO:
0.45
NVDA:
3.12
SLNO:
1.06
NVDA:
3.43
SLNO:
1.12
NVDA:
1.43
SLNO:
0.27
NVDA:
6.05
SLNO:
1.90
NVDA:
18.75
SLNO:
13.36%
NVDA:
8.72%
SLNO:
57.06%
NVDA:
52.34%
SLNO:
-99.86%
NVDA:
-89.73%
SLNO:
-93.12%
NVDA:
-12.22%
Fundamentals
SLNO:
$2.07B
NVDA:
$3.19T
SLNO:
-$2.79
NVDA:
$2.53
SLNO:
0.00
NVDA:
0.81
SLNO:
$3.45M
NVDA:
$113.27B
SLNO:
$1.97M
NVDA:
$85.93B
SLNO:
-$136.50M
NVDA:
$74.87B
Returns By Period
In the year-to-date period, SLNO achieves a 12.22% return, which is significantly lower than NVDA's 163.96% return. Over the past 10 years, SLNO has underperformed NVDA with an annualized return of -9.61%, while NVDA has yielded a comparatively higher 74.71% annualized return.
SLNO
12.22%
-12.78%
10.74%
25.44%
11.74%
-9.61%
NVDA
163.96%
-11.10%
-0.06%
171.70%
85.71%
74.71%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SLNO vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SLNO vs. NVDA - Dividend Comparison
SLNO has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.03%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SLNO Soleno Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% | 1.94% |
Drawdowns
SLNO vs. NVDA - Drawdown Comparison
The maximum SLNO drawdown since its inception was -99.86%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for SLNO and NVDA. For additional features, visit the drawdowns tool.
Volatility
SLNO vs. NVDA - Volatility Comparison
Soleno Therapeutics, Inc. (SLNO) has a higher volatility of 12.79% compared to NVIDIA Corporation (NVDA) at 9.43%. This indicates that SLNO's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SLNO vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities